Tauchi, Tetsuzo <br/><br/>
The second generation of BCR-ABL tyrosine kinase inhibitors.  [electronic resource] 

 -  International journal of hematology  May 2006 
 - 294-300 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0925-5710 
<br/><br/><label>Standard No.: </label>10.1532/IJH97.06025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allosteric Regulation--drug effects<br/>Antineoplastic Agents--chemistry<br/>Binding Sites--drug effects<br/>Drug Design<br/>Drug Resistance, Neoplasm--drug effects<br/>Fusion Proteins, bcr-abl<br/>Gene Amplification--drug effects<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Mutation<br/>Philadelphia Chromosome<br/>Protein Binding--drug effects<br/>Protein Kinase Inhibitors--chemistry<br/>Protein Structure, Tertiary--drug effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors